mTOR Pathway and mTOR Inhibitors in Head and Neck Cancer

Head and neck cancer is the sixth most common type of Cancer worldwide. Since conventional treatment regimens are nonselective and are associated with systemic toxicities, intense investigations focus on molecular targeted therapy with high selectivity and low adverse effects. mTOR signaling pathway...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Wei, Li, John Zeng Hong, Chan, Jimmy Yu Wai, Ho, Wai Kuen, Wong, Thian-Sze
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671705/
https://www.ncbi.nlm.nih.gov/pubmed/23762622
http://dx.doi.org/10.5402/2012/953089